Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |